India's Health Ministry has amended the Drugs Rules, 1945 to strengthen transparency in drug regulation. Applicants submitting fake or fabricated data or documents may be barred from filing new applications for a specified period. The move aims to ensure drug approvals rely on reliable scientific evidence and strengthen accountability, safety and regulatory compliance.